Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
HETEROCYCLIC COMPOUNDS AS KRAS INHIBITORS, AND PREPARATION AND THERAPEUTIC USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/046370
Kind Code:
A1
Abstract:
The present invention relates to compounds of formula (I) and formula (II), or pharmaceutically acceptable salts, prodrugs, tautomers, or stereoisomers and solvates thereof. Said compounds can be used for the treatment of cancers and inflammations of mammals. Also disclosed in the present invention are preparation methods for the compounds of formula (I) and formula (II), and pharmaceutical compositions comprising the compounds.

Inventors:
TIAN HONGQI (CN)
HUANG GONGCHAO (CN)
GAO XUGUANG (CN)
LIU HUANHUAN (CN)
Application Number:
PCT/CN2023/115860
Publication Date:
March 07, 2024
Filing Date:
August 30, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI KECHOW PHARMA INC (CN)
International Classes:
C07D519/00; A61K31/517; A61K31/519; A61P35/00
Domestic Patent References:
WO2023122662A12023-06-29
WO2023150284A22023-08-10
WO2022221739A12022-10-20
WO2022232331A12022-11-03
WO2021219072A12021-11-04
Foreign References:
CN113999226A2022-02-01
TW202241869A2022-11-01
Other References:
ZHANG ZIYANG, GUILEY KEELAN Z., SHOKAT KEVAN M.: "Chemical acylation of an acquired serine suppresses oncogenic signaling of K-Ras(G12S)", NATURE CHEMICAL BIOLOGY, NATURE PUBLISHING GROUP US, NEW YORK, vol. 18, no. 11, 1 November 2022 (2022-11-01), New York, pages 1177 - 1183, XP093032812, ISSN: 1552-4450, DOI: 10.1038/s41589-022-01065-9
Attorney, Agent or Firm:
WU, FENG & ZHANG (CN)
Download PDF: